Skip to content

Prevalence of Upper Limb Musculoskeletal Abnormalities in Type 2 Diabetic Patients and Its Relation to Hypoglycemic Control.

Prevalence of Upper Limb Musculoskeletal Abnormalities in Type 2 Diabetic Patients and Its Relation to Glycemic Control.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05819671
Enrollment
400
Registered
2023-04-19
Start date
2022-11-01
Completion date
2023-05-31
Last updated
2023-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Limb Musculoskeletal Abnormalities

Brief summary

to investigate prevalence of upper limb musculoskeletal disorders and correlations to glycemic control.

Detailed description

). DM is associated with a number of complications including renal disease, peripheral neuropathy, retinopathy, vascular events and musculoskeletal complications. DM is complicated by musculoskeletal problems of upper extremity and particularly the hand, collectively referred as the diabetic hand. (3) The most common upper limb musculoskeletal disorders associated with DM are adhesive capsulitis, rotator's cuff tendinitis, limited joint mobility (LJM), Dupuytren's disease (DD), trigger finger (TF), and carpal tunnel syndrome (CTS). Upper limb musculoskeletal disorders affect hand functions and activities of daily living (ADL). Aim of the study: to investigate prevalence of upper limb musculoskeletal disorders and correlations to glycemic control. Inclusion criteria: patients will be included to this study(cases) if they are: 1\) Diabetic patients. 2) Age \> 18 years. 3) Diagnosed as type 2. Exclusion criteria: Patients will be excluded if they have rheumatoid arthritis, other rheumatological diseases or previous upper limb surgeries. Sample size calculation: By reviewing literature, it is found that the most relevant study (3) to our work found that the prevalence of upper limb musculoskeletal abnormalities in type 2 diabetic patients is .22 and for control group is .05 so, by using piface calculator (version 1.76) to calculate sample size (power = 0.8, alpha error = 0.05 and beta= 0.2) it is found that we need 71 participants for every group. To increase power of the study will enroll 100 participants for every group.

Interventions

None listed

Sponsors

Eslam Elsayed Ali Shohda
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients will be included to this study(cases) if they are: 1) Diabetic patients. 2) Age \> 18 years. 3) Diagnosed as type 2.

Exclusion criteria

\- Patients will be excluded if they have rheumatoid arthritis, other rheumatological diseases or previous upper limb surgeries.

Design outcomes

Primary

MeasureTime frame
prevalence of upper limb musculoskeletal disorders and correlations to glycemic control3 months

Countries

Egypt

Contacts

Primary ContactEslam Elsayed Shohda, PHD,PT
dreslamelsayed@hotmail.com01009482231
Backup ContactHadder Khaled Abd elhameed, DPT
dreslamelsayed@hotmail.com01112663032

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026